DiscoverMolecular Modelling and Drug DiscoveryFragment-Based Hit Discovery via Unsupervised Learning of Fragment-Protein Complexes | William McCorkindale
Fragment-Based Hit Discovery via Unsupervised Learning of Fragment-Protein Complexes | William McCorkindale

Fragment-Based Hit Discovery via Unsupervised Learning of Fragment-Protein Complexes | William McCorkindale

Update: 2023-03-30
Share

Description

[DISCLAIMER] - For the full visual experience, we recommend you tune in through our ⁠⁠YouTube channel ⁠⁠to see the presented slides.


If you enjoyed this talk, consider joining the ⁠⁠Molecular Modeling and Drug Discovery (M2D2) talks⁠⁠ live.


Also, consider joining the ⁠⁠M2D2 Slack⁠⁠.


Abstract: The process of finding molecules that bind to a target protein is a challenging first step in drug discovery. Crystallographic fragment screening is a strategy based on elucidating binding modes of small polar compounds and then building potency by expanding or merging them. Recent advances in high-throughput crystallography enable screening of large fragment libraries, reading out dense ensembles of fragments spanning the binding site. However, fragments typically have low affinity thus the road to potency is often long and fraught with false starts. Here, we take advantage of high-throughput crystallography to reframe fragment-based hit discovery as a denoising problem – identifying significant pharmacophore distributions from a fragment ensemble amid noise due to weak binders – and employ an unsupervised machine learning method to tackle this problem. Our method screens potential molecules by evaluating whether they recapitulate those fragment-derived pharmacophore distributions. We retrospectively validated our approach on an open science campaign against SARS-CoV-2 main protease (Mpro), showing that our method can distinguish active compounds from inactive ones using only structural data of fragment-protein complexes, without any activity data. Further, we prospectively found novel hits for Mpro and the Mac1 domain of SARS-CoV-2 non-structural protein 3. More broadly, our results demonstrate how unsupervised machine learning helps interpret high throughput crystallography data to rapidly discover of potent chemical modulators of protein function.


Speaker: ⁠William McCorkindale


Twitter -  ⁠⁠Prudencio⁠⁠


Twitter - ⁠⁠Therence⁠⁠


Twitter - ⁠⁠Jonny⁠⁠


Twitter - ⁠⁠Valence Discovery

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Fragment-Based Hit Discovery via Unsupervised Learning of Fragment-Protein Complexes | William McCorkindale

Fragment-Based Hit Discovery via Unsupervised Learning of Fragment-Protein Complexes | William McCorkindale

Valence Discovery